Orphan drugs dominate FDA's record-breaking year

Also worth a mention is Lox/Bayer’s Vitrakvi (larotrectinib), which became the second drug to be approved based on a biomarker across different types of tumours rather than the location

GSK and Pfizer to create combined consumer health titan

technologies.”. The JV will be the biggest over-the-counter (OTC) product player in the world with a market share of 7.3%, ahead of its nearest competitor (Bayer) at

New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics

At Lilly, Mader was most recently a research fellow and group leader, but prior to this she was a visiting research scientists at the Bayer Research Center and an associate professor

Bayer axes 1,250 pharma jobs, with R&D taking the brunt

Part of massive layoff of 12, 000 people across conglomerate. Bayer is shedding around 1, 250 jobs from its pharma division as part of a major restructuring exercise that will see ... The consumer health unit will lose around 1, 100 workers, with crop

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]